In particular, evidence of the translocation of HMGB1 from the nucleus to the cytoplasm of neurons, as revealed by immunohistochemical analysis, strongly supports the notion that HMGB1 is released from neurons during AD’s pathology. Here, HMGB1 is linked to Alzheimer disease.